Minimal residual disease in EGFR-mutant non-small-cell lung cancer

by Nathan T. Bain, Yang Wang, Surein Arulananda, Surein Arulananda, Surein Arulananda, Surein Arulananda
Published 2022-09-01

Uncommon EGFR-Mutant NSCLC—One Drug Does Not Fit All

by Yang Wang, M.B.B.S., Surein Arulananda, M.B.B.S., PhD
Published 2023-04-01

Circulating Tumour DNA (ctDNA) as a Predictor of Clinical Outcome in Non-Small Cell Lung Cancer Undergoing Targeted Therapies: A Systematic Review and Meta-Analysis

by Farzana Y. Zaman, Ashwin Subramaniam, Afsana Afroz, Zarka Samoon, Daniel Gough, Surein Arulananda, Muhammad Alamgeer
Published 2023-04-01

Implementation of a nurse-led, multidisciplinary model of care for older adults with cancer: a process evaluation protocol

by Sagun Parakh, Kathryn Lee, Jeremy Rodrigues, Paul Yates, Polly Hypatia Dufton, Elena Tarasenko, Katrina Midgley, Ray Kelly, Surein Arulananda
Published 2024-01-01

A novel BH3-mimetic, AZD0466, targeting BCL-XL and BCL-2 is effective in pre-clinical models of malignant pleural mesothelioma

by Surein Arulananda, Megan O’Brien, Marco Evangelista, Laura J. Jenkins, Ashleigh R. Poh, Marzena Walkiewicz, Trishe Leong, John M. Mariadason, Jonathan Cebon, Srividya B. Balachander, Justin R. Cidado, Erinna F. Lee, Thomas John, Walter D. Fairlie
Published 2021-05-01

Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy

by Yang Wang, M.B.B.S., Jared Mathai, M.B.B.S., Muhammad Alamgeer, M.B.B.S., DMedSci, Sagun Parakh, MbChB., PhD, Eldho Paul, PhD, Paul Mitchell, MbChB., MD, Surein Arulananda, M.B.B.S., PhD
Published 2023-08-01

Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma

by Surein Arulananda, Megan O’Brien, Marco Evangelista, Tiffany J. Harris, Nikita S. Steinohrt, Laura J. Jenkins, Marzena Walkiewicz, Robert J. J. O’Donoghue, Ashleigh R. Poh, Bibhusal Thapa, David S. Williams, Trishe Leong, John M. Mariadason, Xia Li, Jonathan Cebon, Erinna F. Lee, Thomas John, W. Douglas Fairlie
Published 2021-06-01